Promising Artificial Intelligence Stocks To Keep An Eye On – May 7th

Hut 8, Fluence Energy, and Tempus AI are the three Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. Artificial intelligence stocks are shares of publicly traded companies whose core business or a significant portion of operations involves developing, selling, or integrating AI technologies — such as machine learning models, natural language processing, computer vision, AI chips, or related cloud and service offerings. For investors, these stocks represent exposure to the potential growth and disruption from AI adoption but can vary widely in true AI focus, competitive risk, and valuation, so assessing each company’s business model and degree of AI dependence is important. These companies had the highest dollar trading volume of any Artificial Intelligence stocks within the last several days.

Hut 8 (HUT)

Hut 8 Corp., together with its subsidiaries, acquires, builds, manages, and operates data centers for digital assets mining, computing, and artificial intelligence in the United States. It operates in four segments: Digital Assets Mining, Managed Services, High Performance Computing Colocation and Cloud, and Other.

Read Our Latest Research Report on HUT

Fluence Energy (FLNC)

Fluence Energy, Inc., through its subsidiaries, offers energy storage products and solution, services, and artificial intelligence enabled software-as-a-service products for renewables and storage applications in the Americas, the Asia Pacific, Europe, the Middle East, and Africa. The company sells energy storage products with integrated hardware, software, and digital intelligence.

Read Our Latest Research Report on FLNC

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read Our Latest Research Report on TEM

Featured Articles